Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lofepramine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lofepramine 70mg tablets
0403010R0AAAAAA
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | 33,682 |
|
Lofepramine 70mg/5ml oral suspension sugar free
0403010R0AAALAL
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | 325 |
|
Feprapax 70mg tablets
0403010R0BDAAAA
|
Feprapax | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Gamanil 70mg tablets
0403010R0BBAAAA
|
Gamanil | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lofepramine 140mg/5ml oral liquid
0403010R0AAAHAH
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lofepramine 23mg/5ml oral liquid
0403010R0AAAKAK
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lofepramine 35mg/5ml oral liquid
0403010R0AAAMAM
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lofepramine 5mg/5ml oral liquid
0403010R0AAAIAI
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lofepramine 70mg/5ml oral liquid
0403010R0AAAGAG
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lomont 70mg/5ml oral suspension
0403010R0BCAAAL
|
Lomont | Lofepramine hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.